Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Spectral Medical Inc T.EDT

Alternate Symbol(s):  EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s EAA. PMX is approved for therapeutic use in Japan and Europe and has been used safely and effectively on more than 340,000 patients to date. It has pioneered the development of biochemical markers for the clinical syndrome known as septic shock. It is continuing its legacy business of manufacturing and selling certain proprietary reagents. It develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies.


TSX:EDT - Post by User

Bullboard Posts
Comment by Stocktreeon Mar 01, 2016 5:18pm
139 Views
Post# 24610691

RE:RE:RE:Upcoming DSMB meeting and over-allotment decision...

RE:RE:RE:Upcoming DSMB meeting and over-allotment decision...
Like you, I dream of them stopping the trial because it would be unethical to not treat very sick patients with the best and only option available to them.

Like you, I don't like that insiders seem to be doing everything in their power to prevent small shareholders from profiting from their investment.

Unlike you, I don't want to proclame that the trial will probably end soon, because it would just be a wild guess and because everytime someone does it, it only disappoints people a little bit more. Counterproductive in my opinion.

You often point out interesting things, but then you come to conclusions that don't appear to stick to anything in reality.

Like the fact that the trial might stop because the underwriters have made a poor decision whether the trial stops or not. Of course, If you want to help me gain a better understanding of you point of you, please do.

Also like the fact that sometimes in the past I have come down hard on you or that I use some kind of font or reasoning means that I would be Beecher. Being Beecher or not, what does it matter to you? Let's say I am, just tell me when my posts are right or wrong, thin, misleading or whatever. An alias is just an alias. Since I will stick with Stocktree, it is clearer to everyone that you address me as Stocktree or as a funny version of it, instead of someone most of us don't know.
Bullboard Posts